Direct Effects of Exendin-(9,39) and GLP-1-(9,36)amide on Insulin Action, β-Cell Function, and Glucose Metabolism in Nondiabetic Subjects

Exendin-(9,39) is a competitive antagonist of glucagon-like peptide-1 (GLP-1) at its receptor. However, it is unclear if it has direct and unique effects of its own. We tested the hypothesis that exendin-(9,39) and GLP-1-(9,36)amide have direct effects on hormone secretion and β-cell function as wel...

Descripción completa

Detalles Bibliográficos
Autores principales: Sathananthan, Matheni, Farrugia, Luca P., Miles, John M., Piccinini, Francesca, Dalla Man, Chiara, Zinsmeister, Alan R., Cobelli, Claudio, Rizza, Robert A., Vella, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717878/
https://www.ncbi.nlm.nih.gov/pubmed/23545708
http://dx.doi.org/10.2337/db13-0140

Ejemplares similares

Ejemplares similares